Serglycin: At the Crossroad of Inflammation and Malignancy

Serglycin has been initially characterized as an intracellular proteoglycan expressed by hematopoietic cells. All inflammatory cells highly synthesize serglycin and store it in granules, where it interacts with numerous inflammatory mediators, such as proteases, chemokines, cytokines, and growth fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Korpetinou, Angeliki, Skandalis, Spyros S., Labropoulou, Vassiliki T., Smirlaki, Gianna, Noulas, Argyrios, Karamanos, Nikos K., Theocharis, Achilleas D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888995/
https://www.ncbi.nlm.nih.gov/pubmed/24455486
http://dx.doi.org/10.3389/fonc.2013.00327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888995/
https://www.ncbi.nlm.nih.gov/pubmed/24455486
http://dx.doi.org/10.3389/fonc.2013.00327

Ejemplares similares